
20.21BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US07725L1026
CUSIP
07725L102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
226.72
Dividend Share
-
Dividend Yield
-
Earnings Share
-8.19
Wall Street Target Price
280.92
EPS Estimate Current Year
-5.55
EPS Estimate Next Year
-0.56
EPS Estimate Current Quarter
-1.2
EPS Estimate Next Quarter
-1.3
Most Recent Quarter
-
Revenue TTM
23,507,726,336
Gross Profit TTM
-511,062,000
EBITDA
-5,576,400,384
Profit Margin
-25.50%
Return On Assets TTM
-9.58%
Return On Equity TTM
-23.22%
Revenue Per Share TTM
225.239
Qtly Revenue Growth YOY
39.50%
Diluted Eps TTM
-8.19
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
384
Price Sales TTM
0.8597
Price Book MRQ
5.6058
Enterprise Value Revenue
5
Enterprise Value EBITDA
-11
23.21
1.58%305.59
-2.69%749.10
-2.23%781.00
-2.19%291.41
-1.73%141.09
-1.73%430.29
-1.17%780.25
-1.01%91.73
-0.71%104.83
-0.69%